These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479 [TBL] [Abstract][Full Text] [Related]
6. A pathological study of the association between Lewy body disease and Alzheimer's disease. Gibb WR; Mountjoy CQ; Mann DM; Lees AJ J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826 [TBL] [Abstract][Full Text] [Related]
7. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528 [TBL] [Abstract][Full Text] [Related]
9. Cortical sources of resting state electroencephalographic rhythms in Parkinson's disease related dementia and Alzheimer's disease. Babiloni C; De Pandis MF; Vecchio F; Buffo P; Sorpresi F; Frisoni GB; Rossini PM Clin Neurophysiol; 2011 Dec; 122(12):2355-64. PubMed ID: 21924950 [TBL] [Abstract][Full Text] [Related]
10. Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease. Tunold JA; Tan MMX; Koga S; Geut H; Rozemuller AJM; Valentino R; Sekiya H; Martin NB; Heckman MG; Bras J; Guerreiro R; Dickson DW; Toft M; van de Berg WDJ; Ross OA; Pihlstrøm L Brain; 2023 Oct; 146(10):4077-4087. PubMed ID: 37247383 [TBL] [Abstract][Full Text] [Related]
11. Assessment of genetic risk for improved clinical-neuropathological correlations. Spencer BE; Jennings RG; Fan CC; Brewer JB Acta Neuropathol Commun; 2020 Sep; 8(1):160. PubMed ID: 32912321 [TBL] [Abstract][Full Text] [Related]
12. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH; Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334 [TBL] [Abstract][Full Text] [Related]
13. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology. de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516 [TBL] [Abstract][Full Text] [Related]
14. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease. Farlow MR; Cummings J Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077 [TBL] [Abstract][Full Text] [Related]
15. 'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. de Vos RA; Jansen EN; Stam FC; Ravid R; Swaab DF Clin Neurol Neurosurg; 1995 Feb; 97(1):13-22. PubMed ID: 7788967 [TBL] [Abstract][Full Text] [Related]
16. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501 [TBL] [Abstract][Full Text] [Related]